Palmitoylated STX11 suppresses AMPK to drive lipogenesis and colorectal cancer

Key Points

• Palmitoylated STX11 drives lipogenesis in colorectal cancer cells, enhancing tumor growth.
• The study shows a significant decrease in AMPK activity associated with high levels of STX11.
• Using biochemical assays, researchers analyzed the impact of STX11 on metabolic pathways in cancer cells.
• These findings may suggest potential therapeutic targets for colorectal cancer based on metabolic regulation.